The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Hepatic Ischemia/Reperfusion Injury Involves Functional TLR4 Signaling in Nonparenchymal Cells
Open accessAbstract
Endogenous ligands from damaged cells, so-called damage-associated molecular pattern molecules, can activate innate immunity via TLR4 signaling. Hepatic warm ischemia and reperfusion (I/R) injury and inflammation is largely TLR4 dependent. We produced TLR4 chimeric mice to assess whether the TLR4-dependent injury required TLR4 expression on liver parenchymal or nonparenchymal cells. Chimeric mice were produced by adoptive transfer of donor bone marrow cells into irradiated recipient animals using reciprocal combinations of TLR4 wild-type (WT; C3H/HeOuj) and TLR4 mutant (C3H/HeJ) mouse bone marrow. Wild-type chimeric mice bearing TLR4 mutant hemopoietic cells and TLR4 mutant mice transplanted with their own bone marrow-derived cells were protected from hepatic I/R and exhibited decreased JNK and NF-κB activation compared with WT chimeric mice transplanted with their own bone marrow. In contrast, TLR4 mutant mice transplanted with TLR4 WT bone marrow were not protected from liver I/R and demonstrated pronounced increases in JNK and NF-κB activation when compared with autochthonous transplanted mutant mice. In addition, depletion of phagocytes taking up gadolinium chloride failed to provide any additional protection to TLR4 mutant mice, but substantially reduced damage in WT mice after hepatic I/R. Together, these results demonstrate that TLR4 engagement on actively phagocytic nonparenchymal cells such as Kupffer cells is required for warm I/R-induced injury and inflammation in the liver.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312
Chapter 4 Preparation of Isolated Rat Liver Cells
Seglen, P. O. (1976) · Methods in Cell Biology · doi:10.1016/s0091-679x(08)61797-5 · Cited by 5,310
HMG-1 as a Late Mediator of Endotoxin Lethality in Mice
Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L., et al. (1999) · Science · doi:10.1126/science.285.5425.248 · Cited by 3,385
Park, J. S., Svetkauskaite, D., He, Q., Kim, J.-Y., Strassheim, D., Ishizaka, A., & Abraham, E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306793200 · Cited by 1,562
Whitmarsh, A. J., & Davis, R. J. (1996) · Journal of Molecular Medicine · doi:10.1007/s001090050063 · Cited by 1,543
Oligosaccharides of Hyaluronan Activate Dendritic Cells via Toll-like Receptor 4
Termeer, C., Benedix, F., Sleeman, J., Fieber, C., Voith, U., Ahrens, T., Miyake, K., Freudenberg, M., Galanos, C., & Simon, J. C. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20001858 · Cited by 1,378
Reversing established sepsis with antagonists of endogenous high-mobility group box 1
Yang, H., Ochani, M., Li, J., Qiang, X., Tanovic, M., Harris, H. E., Susarla, S. M., Ulloa, L., Wang, H., DiRaimo, R., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2434651100 · Cited by 1,126
The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion
Tsung, A., Sahai, R., Tanaka, H., Nakao, A., Fink, M. P., Lotze, M. T., Yang, H., Li, J., Tracey, K. J., Geller, D. A., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042614 · Cited by 1,113
Self-citationHSP70 as Endogenous Stimulus of the Toll/Interleukin-1 Receptor Signal Pathway
Vabulas, R. M., Ahmad-Nejad, P., Ghose, S., Kirschning, C. J., Issels, R. D., & Wagner, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111204200 · Cited by 948
Fibrinogen Stimulates Macrophage Chemokine Secretion Through Toll-Like Receptor 4
Smiley, S. T., King, J. A., & Hancock, W. W. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.5.2887 · Cited by 946
Cited by
Cell Biology of Ischemia/Reperfusion Injury
(2012) · International Review of Cell and Molecular Biology · doi:10.1016/b978-0-12-394309-5.00006-7 · Cited by 2,178
TLR4 enhances TGF-β signaling and hepatic fibrosis
Seki, E., De Minicis, S., Österreicher, C. H., Kluwe, J., Osawa, Y., Brenner, D. A., & Schwabe, R. F. (2007) · Nature Medicine · doi:10.1038/nm1663 · Cited by 1,942
Ischaemia–reperfusion injury in liver transplantation—from bench to bedside
Zhai, Y., Petrowsky, H., Hong, J. C., Busuttil, R. W., & Kupiec-Weglinski, J. W. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.225 · Cited by 843
Antigen-presenting cell function in the tolerogenic liver environment
Thomson, A. W., & Knolle, P. A. (2010) · Nature Reviews Immunology · doi:10.1038/nri2858 · Cited by 805
HMGB1: Endogenous Danger Signaling
Klune, J. R., Dhupar, R., Cardinal, J., Billiar, T. R., & Tsung, A. (2008) · Molecular Medicine · doi:10.2119/2008-00034.klune · Cited by 762
Self-citationToll‐like receptors and adaptor molecules in liver disease: Update†
Seki, E., & Brenner, D. A. (2008) · Hepatology · doi:10.1002/hep.22306 · Cited by 722
Kalogeris, T., Baines, C. P., Krenz, M., & Korthuis, R. J. (2016) · Comprehensive Physiology · doi:10.1002/cphy.c160006 · Cited by 718
Sterile inflammation in the liver
Kubes, P., & Mehal, W. Z. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.09.008 · Cited by 666
Tsung, A., Klune, J. R., Zhang, X., Jeyabalan, G., Cao, Z., Peng, X., Stolz, D. B., Geller, D. A., Rosengart, M. R., & Billiar, T. R. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070247 · Cited by 620
Self-citationHigh‐mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity
Bianchi, M. E., & Manfredi, A. A. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00574.x · Cited by 600
“Significantly, hepatic ischemia/reperfusion damage, which is mediated by HMGB1 (37), involves TLR4 signaling (59).”
BackgroundLinking oxidative stress to inflammation: Toll-like receptors
Gill, R., Tsung, A., & Billiar, T. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.01.006 · Cited by 553
“TLR4 is expressed by both immune cells and parenchymal or non-immune cells [35-38].”
BackgroundSelf-citationHuang, H., Tohme, S., Al‐Khafaji, A. B., Tai, S., Loughran, P., Chen, L., Wang, S., Kim, J., Billiar, T., Wang, Y., et al. (2015) · Hepatology · doi:10.1002/hep.27841 · Cited by 540
Self-citationVollmar, B., & Menger, M. D. (2009) · Physiological Reviews · doi:10.1152/physrev.00027.2008 · Cited by 500
Inflammasomes in liver diseases
Szabo, G., & Csak, T. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.03.035 · Cited by 495
Li, W., Feng, G., Gauthier, J. M., Lokshina, I., Higashikubo, R., Evans, S., Liu, X., Hassan, A., Tanaka, S., Cicka, M., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci126428 · Cited by 492
Jaeschke, H. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00568.2005 · Cited by 475
Kupffer cells in non-alcoholic fatty liver disease: The emerging view
Baffy, G. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.03.008 · Cited by 473
Zhai, Y., Busuttil, R. W., & Kupiec-Weglinski, J. W. (2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03579.x · Cited by 412
Role of the inflammasome in acetaminophen-induced liver injury and acute liver failure
Woolbright, B. L., & Jaeschke, H. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.11.017 · Cited by 390
Chen, C.-L., Uthaya Kumar, D. B., Punj, V., Xu, J., Sher, L., Tahara, S. M., Hess, S., & Machida, K. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.004 · Cited by 388
RetractedThe importance of immune dysfunction in determining outcome in acute liver failure
Antoniades, C. G., Berry, P. A., Wendon, J. A., & Vergani, D. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.08.009 · Cited by 367
Liver ischemia/reperfusion injury: Processes in inflammatory networks—A review
Abu-Amara, M., Yang, S. Y., Tapuria, N., Fuller, B., Davidson, B., & Seifalian, A. (2010) · Liver Transplantation · doi:10.1002/lt.22117 · Cited by 362
Masquerader: High Mobility Group Box-1 and Cancer
Ellerman, J. E., Brown, C. K., de Vera, M., Zeh, H. J., Billiar, T., Rubartelli, A., & Lotze, M. T. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1953 · Cited by 355
Self-citationApoptosis and Necrosis in the Liver
Guicciardi, M. E., Malhi, H., Mott, J. L., & Gores, G. J. (2013) · Comprehensive Physiology · doi:10.1002/cphy.c120020 · Cited by 353
Huang, H., Evankovich, J., Yan, W., Nace, G., Zhang, L., Ross, M., Liao, X., Billiar, T., Xu, J., Esmon, C. T., et al. (2011) · Hepatology · doi:10.1002/hep.24501 · Cited by 352
Self-citationRole of the Kupffer Cell in Mediating Hepatic Toxicity and Carcinogenesis
Roberts, R. A., Ganey, P. E., Ju, C., Kamendulis, L. M., Rusyn, I., & Klaunig, J. E. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfl173 · Cited by 331
Role of Neutrophils in the Pathogenesis of Acute Inflammatory Liver Injury
Ramaiah, S. K., & Jaeschke, H. (2007) · Toxicologic Pathology · doi:10.1080/01926230701584163 · Cited by 328
Microbiota-liver axis in hepatic disease
Chassaing, B., Etienne-Mesmin, L., & Gewirtz, A. T. (2014) · Hepatology · doi:10.1002/hep.26494 · Cited by 326
Cancer and Inflammation: Promise for Biologic Therapy
Demaria, S., Pikarsky, E., Karin, M., Coussens, L. M., Chen, Y.-C., El-Omar, E. M., Trinchieri, G., Dubinett, S. M., Mao, J. T., Szabo, E., et al. (2010) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181d32e74 · Cited by 325
Self-citationGlobal Consequences of Liver Ischemia/Reperfusion Injury
Nastos, C., Kalimeris, K., Papoutsidakis, N., Tasoulis, M.-K., Lykoudis, P. M., Theodoraki, K., Nastou, D., Smyrniotis, V., & Arkadopoulos, N. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/906965 · Cited by 311
Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis
Guo, J., & Friedman, S. L. (2010) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-3-21 · Cited by 311
EMERGING PARADIGM: TOLL-LIKE RECEPTOR 4-SENTINEL FOR THE DETECTION OF TISSUE DAMAGE
Mollen, K. P., Anand, R. J., Tsung, A., Prince, J. M., Levy, R. M., & Billiar, T. R. (2006) · Shock · doi:10.1097/01.shk.0000228797.41044.08 · Cited by 305
Self-citationInhibition of toll‐like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis
Abdollahi‐Roodsaz, S., Joosten, L. A. B., Roelofs, M. F., Radstake, T. R. D. J., Matera, G., Popa, C., van der Meer, J. W. M., Netea, M. G., & van den Berg, W. B. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22848 · Cited by 302
TOLL-LIKE RECEPTORS IN ISCHEMIA-REPERFUSION INJURY
Arumugam, T. V., Okun, E., Tang, S.-C., Thundyil, J., Taylor, S. M., & Woodruff, T. M. (2009) · Shock · doi:10.1097/shk.0b013e318193e333 · Cited by 300
Protective mechanisms of end-ischemic cold machine perfusion in DCD liver grafts
Schlegel, A., Rougemont, O. D., Graf, R., Clavien, P.-A., & Dutkowski, P. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.10.004 · Cited by 274
Contribution of Gut Bacteria to Liver Pathobiology
Son, G., Kremer, M., & Hines, I. N. (2010) · Gastroenterology Research and Practice · doi:10.1155/2010/453563 · Cited by 183
Hemorrhagic Shock Activation of NLRP3 Inflammasome in Lung Endothelial Cells
Xiang, M., Shi, X., Li, Y., Xu, J., Yin, L., Xiao, G., Scott, M. J., Billiar, T. R., Wilson, M. A., & Fan, J. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102093 · Cited by 155
Self-citationHu, Q., Wood, C. R., Cimen, S., Venkatachalam, A. B., & Alwayn, I. P. J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0140105 · Cited by 75
“MTDs express at least two molecular signatures, formyl peptides and mitochondrial DNA (mtDNA) that act on formyl peptide receptors (FPRs) and Toll-like receptors (TLRs), respectively [21,22].”
Background
Metadata
- Authors
- Tsung, A., Hoffman, R. A., Izuishi, K., Critchlow, N. D., Nakao, A., Chan, M. H., Lotze, M. T., Geller, D. A., & Billiar, T. R.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-12-01
- Volume
- 175
- Issue
- 11
- Pages
- 7661-7668
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2167097725
- Cited by
- 365
- References
- 45
- FWCI
- 6.55
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.